SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-22-230084
Filing Date
2022-08-25
Accepted
2022-08-25 16:51:03
Documents
7
Period of Report
2022-08-23

Document Format Files

Seq Description Document Type Size
1 PREM14A d312295dprem14a.htm PREM14A 1509603
2 EX-FILING FEES d312295dexfilingfees.htm EX-FILING FEES 16024
3 GRAPHIC g312295g01a10.jpg GRAPHIC 29625
4 GRAPHIC g312295g02a05.jpg GRAPHIC 63294
5 GRAPHIC g312295g07a36.jpg GRAPHIC 52075
6 GRAPHIC g312295g58n75.jpg GRAPHIC 9286
7 GRAPHIC g312295lg1.jpg GRAPHIC 7169
  Complete submission text file 0001193125-22-230084.txt   1743342
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: PREM14A | Act: 34 | File No.: 000-14902 | Film No.: 221198255
SIC: 2835 In Vitro & In Vivo Diagnostic Substances